Edesa Biotech, Inc.
EDSA
$7.69
$0.699.86%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 18.71% | 2.67% | -16.13% | -14.68% | -15.39% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.40% | 12.78% | -23.08% | -23.94% | -18.91% |
| Operating Income | -18.40% | -12.78% | 23.08% | 23.94% | 18.91% |
| Income Before Tax | -27.95% | -16.46% | 14.57% | 19.42% | 20.85% |
| Income Tax Expenses | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Earnings from Continuing Operations | -27.94% | -16.46% | 14.56% | 19.42% | 20.85% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -27.94% | -16.46% | 14.56% | 19.42% | 20.85% |
| EBIT | -18.40% | -12.78% | 23.08% | 23.94% | 18.91% |
| EBITDA | -20.09% | -14.11% | 23.18% | 24.07% | 19.35% |
| EPS Basic | 39.02% | 30.27% | 39.77% | 32.47% | 27.68% |
| Normalized Basic EPS | 42.90% | 30.03% | 43.82% | 33.90% | 23.87% |
| EPS Diluted | 39.02% | 30.27% | 39.77% | 32.47% | 27.68% |
| Normalized Diluted EPS | 42.90% | 30.03% | 43.82% | 33.90% | 23.87% |
| Average Basic Shares Outstanding | 110.31% | 77.70% | 50.53% | 23.14% | 8.95% |
| Average Diluted Shares Outstanding | 110.31% | 77.70% | 50.53% | 23.14% | 8.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |